BRD4 plays a role in cancer by promoting oncogene expression.[20] Although the mRNA level of NT5C was downregulated upon genetic or pharmacological inhibition of BRD4, the expression pattern of NT5C and its clinical relevance indicated that it might be a tumor suppressor in ESCC. Here, NT5C is linked to neoplasm.